banner

Latest News

Ample Secures $31 Million Series A to Bring Energy to Electric Cars

Reported in The Wall Street Journal, Electrek.co, and Business Wire: Ample Secures $31 Million Series A to Bring Energy to Electric Cars Ample, a technology company focused on solving the energy delivery challenge for electric cars, co-founded by Khaled Hassounah and John de Souza, announced today that it has closed a $31 million Series A round of financing. Shell Ventures led the inv...

Read More

Wild Earth Closes Seed Funding Round with $450K Investment from Founders Fund and Peter Thiel

From PR Newswire: Wild Earth Closes Seed Funding Round with $450K Investment from Founders Fund and Peter Thiel BERKELEY, Calif., July 30, 2018 /PRNewswire/ -- Wild Earth, Inc., a biotech startup developing clean protein pet foods, today announced it has successfully completed its seed round with an investment from Pathfinder, the early stage investment vehicle of Founders Fund...

Read More

Manus Bio makes series A breakthrough

A recent article on Manus Bio: The MIT spinout has raised $19.4m from unnamed backers, and the plant-based ingredient developer will use the cash to expand its production capacity. Manus Bio, a US-based natural ingredient supplier spun out from Massachusetts Institute of Technology (MIT), has secured $19.4m in a series A round backed by unnam...

Read More

Remote Monitoring Offers Opportunity to Improve Patient Care

A recent article highlighting Pillo Health: When Reena Sangar recently had a sore throat, she photographed it and sent the image to her doctor. Within 8 minutes, she had a message telling her how to manage it. “That kind of technology is transformative for me as a user,” said Sangar, head of digital and connective health at Ipsos, a global research and consulting fi...

Read More

Rapid 3D Printing Of High-Res, Viable Human Organs Possible

A recent  report about Prellis Biologics: It can be estimated that every year, in the United States alone, about 900,000 deaths can be prevented if there was no shortage of organs, or if transplants were not delayed and readily available to patients of organ failure. In fact, a Forbes study has ranked the lack of tissue transplants as one of the leading causes of death in Ameri...

Read More

Rocket Pharma - Initiation of Research Coverage by William Blair & Company Announced

From William Blair & Company: Initiation of Research Coverage for Two Gene Therapy Companies William Blair & Company initiated research coverage of two gene therapy companies—Krystal Biotech, Inc. (KRYS $15.07) and Rocket Pharmaceuticals, Inc. (RCKT $19.17). Analyst Raju Prasad said that shares of Krystal Biotech hold a positive risk/reward profile ahead of clinical dat...

Read More

Evonetix, Durham University Partner on £1.3M Project to Develop DNA Synthesis Method

From Genome Web: Evonetix, Durham University Partner on £1.3M Project to Develop DNA Synthesis Method British synthetic biology firm Evonetix said today that it has launched a £1.3 million ($1.7 million) project in partnership with Durham University to develop a proprietary method for DNA synthesis. Evonetix's core technology uses an addressable silicon array to direct the synthesi...

Read More



Catalog Hauls in $9M to Make DNA-Based Data Storage Commercially Viable

From Xconomy: Catalog Hauls in $9M to Make DNA-Based Data Storage Commercially Viable The practice of encoding data in DNA molecules could be inching closer to graduating from research labs to finding practical commercial use. In the coming years, the explosion of data being generated by computing devices could outstrip the supply of hard drives needed to store it, some indust...

Read More